Showing results (111-120 of 319) with videos related to
Sort By:
Pageof 32
Scientific Reports|November 22, 2018
Author Correction: Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant AscitesSungsik Kim, Soochi Kim, Jinhyun Kim, et al.Biomedicines|December 24, 2021
Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer CellsJi Hee Ha, Muralidharan Jayaraman, Revathy Nadhan, et al.Obstetrics & Gynecology Science|March 23, 2016
Prognostic factors in neuroendocrine cervical carcinomaDa Yong Lee, Chul Chong, Maria Lee, et al.Journal of Clinical Medicine|July 26, 2020
A Randomized Controlled Trial of Thermo-Sensitive Sol-Gel Anti-Adhesion Agent after Gynecologic SurgeryYoung Im Kim, Maria Lee, Se Ik Kim, et al.Cancer Letters|December 25, 2004
Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean womenWoong Ju, Sokbom Kang, Jae Weon Kim, et al.Carcinogenesis|April 5, 2018
Ovarian cancer therapeutic potential of glutamine depletion based on GS expressionAkiko Furusawa, Morikazu Miyamoto, Masashi Takano, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Claudin 10 is a glandular epithelial marker in the chicken model as human epithelial ovarian cancerHee Won Seo, Deivendran Rengaraj, Jin Won Choi, et al.Journal of Traditional and Complementary Medicine|July 17, 2020
Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cellsJi Hee Ha, Muralidharan Jayaraman, Rangasudhagar Radhakrishnan, et al.Plos One|October 3, 2013
The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cellsAkechai Im-aram, Lee Farrand, Seung-Min Bae, et al.In Vivo (Athens, Greece)|April 28, 2019
Bevacizumab Efficacy and Recurrence Pattern of Persistent and Metastatic Cervical CancerNara Lee, Se Ik Kim, Maria Lee, et al.Pageof 32